Skip to main content
. 2022 Aug 11;8(8):e10164. doi: 10.1016/j.heliyon.2022.e10164

Figure 4.

Figure 4

Correlation analysis of RiskScore with clinicopathological characteristics using the TCGA-LUAD cohort. RiskScore was related to pathological stage (A), T-stage (B), N-stage (C), tumor status (D), residual tumor (E), and treatment outcome (F). Statistical tests were performed using the Wilcoxon rank sum test. CR, complete remission/response; PD, progressive disease; PR, partial remission/response; SD, stable disease.